- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
Ferrous Glycine Sulfate is a hematological drug used to treat iron deficiency anemia. It is a type of iron supplement that is used to increase the amount of iron in the body. It is available in both oral and injectable forms. The drug is used to treat anemia caused by iron deficiency, as well as to prevent iron deficiency in people who are at risk of developing it. It is also used to treat anemia caused by other conditions, such as chronic kidney disease.
Ferrous Glycine Sulfate is a widely used drug in the hematological drugs market. It is used to treat a variety of conditions, including iron deficiency anemia, and is available in both oral and injectable forms. The drug is generally well tolerated and has few side effects.
Some companies in the Ferrous Glycine Sulfate market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more